BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19380697)

  • 21. A patient with 41 CAG repeats in SCA17 presenting with parkinsonism and chorea.
    Park H; Jeon BS; Shin JH; Park SH
    Parkinsonism Relat Disord; 2016 Jan; 22():106-7. PubMed ID: 26613966
    [No Abstract]   [Full Text] [Related]  

  • 22. Mutation analysis of the TATA box-binding protein (TBP) gene in Chinese Han patients with spinocerebellar ataxia.
    Xu Q; Li XH; Wang JL; Jiang H; Zhang S; Lei LF; Shen L; Xia K; Pan Q; Long ZG; Tang BS
    J Clin Neurosci; 2009 Oct; 16(10):1374-5. PubMed ID: 19581089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotypic homogeneity of the Huntington disease-like presentation in a SCA17 family.
    Schneider SA; van de Warrenburg BP; Hughes TD; Davis M; Sweeney M; Wood N; Quinn NP; Bhatia KP
    Neurology; 2006 Nov; 67(9):1701-3. PubMed ID: 17101913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parkinsonism and nigrostriatal dysfunction are associated with spinocerebellar ataxia type 6 (SCA6).
    Khan NL; Giunti P; Sweeney MG; Scherfler C; Brien MO; Piccini P; Wood NW; Lees AJ
    Mov Disord; 2005 Sep; 20(9):1115-9. PubMed ID: 15954136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 99mTc-TRODAT-1 imaging of multiple system atrophy.
    Lu CS; Weng YH; Chen MC; Chen RS; Tzen KY; Wey SP; Ting G; Chang HC; Yen TC
    J Nucl Med; 2004 Jan; 45(1):49-55. PubMed ID: 14734673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Imaging of dopamine transporter with Tc99m-Trodat-SPECT in movement disorders].
    Kanyó B; Argyelán M; Dibó G; Szakonyi Z; Vécsei L; Fülöp F; Láncz A; Forgács P; Pávics L
    Ideggyogy Sz; 2003 Jul; 56(7-8):231-40. PubMed ID: 12971118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spinocerebellar Ataxia Type 17 (SCA17).
    Toyoshima Y; Takahashi H
    Adv Exp Med Biol; 2018; 1049():219-231. PubMed ID: 29427105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of effect of polymorphisms in dopamine metabolism related genes on imaging of TRODAT-1 in striatum of asymptomatic volunteers and patients with Parkinson's disease.
    Lynch DR; Mozley PD; Sokol S; Maas NM; Balcer LJ; Siderowf AD
    Mov Disord; 2003 Jul; 18(7):804-12. PubMed ID: 12815660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease.
    Siderowf A; Newberg A; Chou KL; Lloyd M; Colcher A; Hurtig HI; Stern MB; Doty RL; Mozley PD; Wintering N; Duda JE; Weintraub D; Moberg PJ
    Neurology; 2005 May; 64(10):1716-20. PubMed ID: 15911797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigating the role of 99mTc-TRODAT-1 SPECT imaging in idiopathic Parkinson's disease.
    Geng Y; Shi GH; Jiang Y; Xu LX; Hu XY; Shao YQ
    J Zhejiang Univ Sci B; 2005 Jan; 6(1):22-7. PubMed ID: 15593387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The striatal dopamine transporter in first-episode, drug-naive schizophrenic patients: evaluation by the new SPECT-ligand[99mTc]TRODAT-1.
    Schmitt GJ; Meisenzahl EM; Frodl T; La Fougère C; Hahn K; Möller HJ; Dresel S
    J Psychopharmacol; 2005 Sep; 19(5):488-93. PubMed ID: 16166186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of genotype on dopamine transporter availability in human striatum and sleep architecture.
    Guindalini C; Martins RC; Andersen ML; Tufik S
    Psychiatry Res; 2010 Sep; 179(2):238-40. PubMed ID: 20493539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presynaptic and postsynaptic nigrostriatal dopaminergic functions in multiple system atrophy.
    Hashimoto M; Kawasaki K; Suzuki M; Mitani K; Murayama S; Mishina M; Oda K; Kimura Y; Ishiwata K; Ishii K; Inoue K
    Neuroreport; 2008 Jan; 19(2):145-50. PubMed ID: 18185098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced striatal [123 I]FP-CIT binding in SCA2 patients without parkinsonism.
    Varrone A; Salvatore E; De Michele G; Barone P; Sansone V; Pellecchia MT; Castaldo I; Coppola G; Brunetti A; Salvatore M; Pappatà S; Filla A
    Ann Neurol; 2004 Mar; 55(3):426-30. PubMed ID: 14991822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Striatal dopamine transporter availability and DAT-1 gene in adults with ADHD: no higher DAT availability in patients with homozygosity for the 10-repeat allele.
    Krause J; Dresel SH; Krause KH; La Fougère C; Zill P; Ackenheil M
    World J Biol Psychiatry; 2006; 7(3):152-7. PubMed ID: 16861140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lower dopamine transporter density in an asymptomatic patient with Kleine-Levin syndrome.
    Hoexter MQ; Shih MC; Mendes DD; Godeiro-Junior C; Felicio AC; Fu YK; Tufik S; Bressan RA
    Acta Neurol Scand; 2008 May; 117(5):370-3. PubMed ID: 18028505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genotype-Phenotype Correlations for ATX-TBP (SCA17): MDSGene Systematic Review.
    Rossi M; Hamed M; Rodríguez-Antigüedad J; Cornejo-Olivas M; Breza M; Lohmann K; Klein C; Rajalingam R; Marras C; van de Warrenburg BP
    Mov Disord; 2023 Mar; 38(3):368-377. PubMed ID: 36374860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parkinsonism and essential tremor in a family with pseudo-dominant inheritance of PARK2: an FP-CIT SPECT study.
    Pellecchia MT; Varrone A; Annesi G; Amboni M; Cicarelli G; Sansone V; Annesi F; Rocca FE; Vitale C; Pappatà S; Quattrone A; Barone P
    Mov Disord; 2007 Mar; 22(4):559-63. PubMed ID: 17149727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spinocerebellar ataxia type 17 (SCA17): oculomotor phenotype and clinical characterization of 15 Italian patients.
    Mariotti C; Alpini D; Fancellu R; Soliveri P; Grisoli M; Ravaglia S; Lovati C; Fetoni V; Giaccone G; Castucci A; Taroni F; Gellera C; Di Donato S
    J Neurol; 2007 Nov; 254(11):1538-46. PubMed ID: 17934876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Profile of families with parkinsonism-predominant spinocerebellar ataxia type 2 (SCA2).
    Furtado S; Payami H; Lockhart PJ; Hanson M; Nutt JG; Singleton AA; Singleton A; Bower J; Utti RJ; Bird TD; de la Fuente-Fernandez R; Tsuboi Y; Klimek ML; Suchowersky O; Hardy J; Calne DB; Wszolek ZK; Farrer M; Gwinn-Hardy K; Stoessl AJ
    Mov Disord; 2004 Jun; 19(6):622-9. PubMed ID: 15197699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.